Business Description
Beijing Luzhu Biotechnology Co Ltd
ISIN : CNE100005YD8
Share Class Description:
HKSE:02480: H shareCompare
Compare
Traded in other countries / regions
02480.Hong Kong IPO Date
2023-05-05Description
Beijing Luzhu Biotechnology Co Ltd is a biotechnology company committed to developing human vaccines and therapeutic biologics to prevent and control infectious diseases and treat cancer and autoimmune diseases. Its clinical-stage product candidates comprise one vaccine candidate, LZ901 and two antibody injection product candidates, including K3 and K193. LZ901 is its Core Product.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 18.71 | |||||
| Equity-to-Asset | 0.86 | |||||
| Debt-to-Equity | 0.03 | |||||
| Debt-to-EBITDA | -0.1 | |||||
| Piotroski F-Score | 5/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 36.29 | |||||
| 9-Day RSI | 39.4 | |||||
| 14-Day RSI | 41.51 | |||||
| 6-1 Month Momentum % | 13.27 | |||||
| 12-1 Month Momentum % | -31.02 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 5.97 | |||||
| Quick Ratio | 5.91 | |||||
| Cash Ratio | 5.69 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -0.19 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -26.91 | |||||
| ROA % | -23.83 | |||||
| ROIC % | -54.78 | |||||
| ROC (Joel Greenblatt) % | -57.05 | |||||
| ROCE % | -25.56 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 4.43 | |||||
| Price-to-Tangible-Book | 4.45 | |||||
| EV-to-EBIT | -12.07 | |||||
| EV-to-EBITDA | -12.07 | |||||
| EV-to-FCF | -14.52 | |||||
| Price-to-Net-Current-Asset-Value | 10.25 | |||||
| Price-to-Net-Cash | 10.96 | |||||
| Earnings Yield (Greenblatt) % | -8.29 | |||||
| FCF Yield % | -5.72 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Beijing Luzhu Biotechnology Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | |||
| EPS (TTM) (HK$) | -1.5 | ||
| Beta | 0 | ||
| Volatility % | 75.56 | ||
| 14-Day RSI | 41.51 | ||
| 14-Day ATR (HK$) | 0.94699 | ||
| 20-Day SMA (HK$) | 21.67 | ||
| 12-1 Month Momentum % | -31.02 | ||
| 52-Week Range (HK$) | 17 - 38.2 | ||
| Shares Outstanding (Mil) | 200.99 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Beijing Luzhu Biotechnology Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Beijing Luzhu Biotechnology Co Ltd Stock Events
| Event | Date | Price(HK$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Beijing Luzhu Biotechnology Co Ltd Frequently Asked Questions
What is Beijing Luzhu Biotechnology Co Ltd(HKSE:02480)'s stock price today?
The current price of HKSE:02480 is HK$22.25. The 52 week high of HKSE:02480 is HK$38.20 and 52 week low is HK$17.00.
When is next earnings date of Beijing Luzhu Biotechnology Co Ltd(HKSE:02480)?
The next earnings date of Beijing Luzhu Biotechnology Co Ltd(HKSE:02480) is .
Does Beijing Luzhu Biotechnology Co Ltd(HKSE:02480) pay dividends? If so, how much?
Beijing Luzhu Biotechnology Co Ltd(HKSE:02480) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers